» Articles » PMID: 18631454

Induction of Immunological Tolerance by Apoptotic Cells Requires Caspase-dependent Oxidation of High-mobility Group Box-1 Protein

Overview
Journal Immunity
Publisher Cell Press
Date 2008 Jul 18
PMID 18631454
Citations 298
Authors
Affiliations
Soon will be listed here.
Abstract

The mammalian immune system discriminates between modes of cell death; necrosis often results in inflammation and adaptive immunity, whereas apoptosis tends to be anti-inflammatory and promote immune tolerance. We have examined apoptosis for the features responsible for tolerance; specifically, we looked at the roles of caspases and mitochondria. Our results show that caspase activation targeted the mitochondria to produce reactive oxygen species (ROS), which were critical to tolerance induction by apoptotic cells. ROS oxidized the potential danger signal high-mobility group box-1 protein (HMGB1) released from dying cells and thereby neutralized its stimulatory activity. Apoptotic cells failed to induce tolerance and instead stimulated immune responses by scavenging or by mutating a mitochondrial caspase target protein when ROS activity was prohibited. Similarly, blocking sites of oxidation in HMGB1 prevented tolerance induction by apoptotic cells. These results suggest that caspase-orchestrated mitochondrial events determine the impact of apoptotic cells on the immune response.

Citing Articles

HMGB1 in Septic Muscle Atrophy: Roles and Therapeutic Potential for Muscle Atrophy and Regeneration.

Qi S, Wu Q, Xiang P, Hou C, Kang Z, Chen M J Cachexia Sarcopenia Muscle. 2025; 16(1):e13711.

PMID: 39963819 PMC: 11833301. DOI: 10.1002/jcsm.13711.


ROS anchor PAMPs-mediated extracellular HMGB1 self-association and its dimerization enhances pro-inflammatory signaling.

Kwak M, Han M, Lee Y, Choi S, Kim J, Park I Redox Biol. 2025; 80:103521.

PMID: 39908862 PMC: 11847140. DOI: 10.1016/j.redox.2025.103521.


High Mobility Group Box 1 (HMGB1): Molecular Signaling and Potential Therapeutic Strategies.

Datta S, Rahman M, Koka S, Boini K Cells. 2024; 13(23).

PMID: 39682695 PMC: 11639863. DOI: 10.3390/cells13231946.


Triggering immunogenic death of cancer cells by nanoparticles overcomes immunotherapy resistance.

Mei T, Ye T, Huang D, Xie Y, Xue Y, Zhou D Cell Oncol (Dordr). 2024; 47(6):2049-2071.

PMID: 39565509 DOI: 10.1007/s13402-024-01009-6.


Small-molecule GSDMD agonism in tumors stimulates antitumor immunity without toxicity.

Fontana P, Du G, Zhang Y, Zhang H, Vora S, Hu J Cell. 2024; 187(22):6165-6181.e22.

PMID: 39243763 PMC: 11648675. DOI: 10.1016/j.cell.2024.08.007.


References
1.
Hoppe G, Talcott K, Bhattacharya S, Crabb J, Sears J . Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1. Exp Cell Res. 2006; 312(18):3526-38. DOI: 10.1016/j.yexcr.2006.07.020. View

2.
Tesniere A, Panaretakis T, Kepp O, Apetoh L, Ghiringhelli F, Zitvogel L . Molecular characteristics of immunogenic cancer cell death. Cell Death Differ. 2007; 15(1):3-12. DOI: 10.1038/sj.cdd.4402269. View

3.
Andersson U, Erlandsson-Harris H, Yang H, Tracey K . HMGB1 as a DNA-binding cytokine. J Leukoc Biol. 2002; 72(6):1084-91. View

4.
Heath W, Kurts C, Miller J, Carbone F . Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med. 1998; 187(10):1549-53. PMC: 2212282. DOI: 10.1084/jem.187.10.1549. View

5.
Lakhani S, Masud A, Kuida K, Porter Jr G, Booth C, Mehal W . Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science. 2006; 311(5762):847-51. PMC: 3738210. DOI: 10.1126/science.1115035. View